8-KOther Events

JOHNSON & JOHNSON 8-K Report, Corporate Update (Nov 30, 2011)

Filed November 30, 2011For Securities:JNJ

Summary

This 8-K filing from Johnson & Johnson provides supplemental information regarding the employment arrangements of Michel Orsinger, President and CEO of Synthes, Inc., in connection with Johnson & Johnson's proposed merger with Synthes. The key focus is on the terms of Mr. Orsinger's continued employment with Johnson & Johnson post-merger, aiming to ensure his retention and align his compensation with Johnson & Johnson's structure. Investors should note that Mr. Orsinger will receive a significant retention package, including a lump-sum cash payment upon the expiration of his current Synthes employment agreement and a new employment agreement with Johnson & Johnson. While his base salary and bonus targets will be lower than his Synthes compensation, this is offset by substantial long-term equity grants and a new hire bonus. These arrangements are designed to incentivize Mr. Orsinger to remain with the combined entity, which is a common practice in mergers and acquisitions to retain key leadership talent.

Key Highlights

  • 1Johnson & Johnson entered into an employment agreement with Michel Orsinger, CEO of Synthes, Inc., for his continued role post-merger.
  • 2Mr. Orsinger's current employment agreement with Synthes will expire upon merger completion in exchange for a lump-sum cash payment equivalent to three times his total annual cash compensation.
  • 3Mr. Orsinger will receive a new base salary of $700,000 and eligibility for annual bonuses under Johnson & Johnson's incentive programs.
  • 4His base salary and bonus targets are intentionally set lower than his current Synthes compensation, reflecting a strategic shift in compensation structure.
  • 5A new hire grant of restricted share units valued at $17.2 million is provided, vesting 100% on the third anniversary of the grant date.
  • 6Mr. Orsinger is eligible for annual long-term incentive grants starting in the 2012 performance year, contingent on the merger's closing date.
  • 7A $500,000 sign-on bonus is included, acknowledging the absence of Synthes' performance formulas for his 2012 bonus.

Frequently Asked Questions

The primary purpose of this filing is to provide supplemental disclosure to investors regarding the employment arrangements of Michel Orsinger, the CEO of Synthes, Inc., in connection with Johnson & Johnson's proposed acquisition of Synthes. It details his compensation and role after the merger is completed.

Following the merger, Mr. Orsinger will have his Synthes employment agreement terminated in exchange for a cash payment equal to three times his annual cash compensation. He will then enter into a new employment agreement with Johnson & Johnson, featuring a $700,000 base salary, eligibility for annual bonuses, a $17.2 million restricted share unit grant, and eligibility for future long-term incentive grants. He will also receive a $500,000 sign-on bonus.

Mr. Orsinger's base salary and annual bonus target under the new Johnson & Johnson agreement are less than half of those provided by Synthes under his current agreement. However, this reduction is compensated by significant long-term equity grants and a sign-on bonus, indicating a shift towards performance-based and long-term incentives from Johnson & Johnson.

The employment agreement is contingent on the successful consummation of the merger and completion of Johnson & Johnson's new hire procedures. It also requires Mr. Orsinger to execute a restrictive covenant agreement that includes non-competition, non-solicitation, and confidentiality clauses.